330 related articles for article (PubMed ID: 9420225)
1. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.
Dragic T; Trkola A; Lin SW; Nagashima KA; Kajumo F; Zhao L; Olson WC; Wu L; Mackay CR; Allaway GP; Sakmar TP; Moore JP; Maddon PJ
J Virol; 1998 Jan; 72(1):279-85. PubMed ID: 9420225
[TBL] [Abstract][Full Text] [Related]
2. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1.
Rabut GE; Konner JA; Kajumo F; Moore JP; Dragic T
J Virol; 1998 Apr; 72(4):3464-8. PubMed ID: 9525683
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
[TBL] [Abstract][Full Text] [Related]
4. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
Dragic T; Trkola A; Thompson DA; Cormier EG; Kajumo FA; Maxwell E; Lin SW; Ying W; Smith SO; Sakmar TP; Moore JP
Proc Natl Acad Sci U S A; 2000 May; 97(10):5639-44. PubMed ID: 10779565
[TBL] [Abstract][Full Text] [Related]
5. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
[TBL] [Abstract][Full Text] [Related]
6. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.
Blanpain C; Doranz BJ; Vakili J; Rucker J; Govaerts C; Baik SS; Lorthioir O; Migeotte I; Libert F; Baleux F; Vassart G; Doms RW; Parmentier M
J Biol Chem; 1999 Dec; 274(49):34719-27. PubMed ID: 10574939
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
Kuhmann SE; Platt EJ; Kozak SL; Kabat D
J Virol; 1997 Nov; 71(11):8642-56. PubMed ID: 9343222
[TBL] [Abstract][Full Text] [Related]
8. Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.
Cashin K; Roche M; Sterjovski J; Ellett A; Gray LR; Cunningham AL; Ramsland PA; Churchill MJ; Gorry PR
J Virol; 2011 Oct; 85(20):10699-709. PubMed ID: 21835796
[TBL] [Abstract][Full Text] [Related]
9. CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.
Lin G; Lee B; Haggarty BS; Doms RW; Hoxie JA
J Virol; 2001 Nov; 75(22):10766-78. PubMed ID: 11602718
[TBL] [Abstract][Full Text] [Related]
10. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
Siciliano SJ; Kuhmann SE; Weng Y; Madani N; Springer MS; Lineberger JE; Danzeisen R; Miller MD; Kavanaugh MP; DeMartino JA; Kabat D
J Biol Chem; 1999 Jan; 274(4):1905-13. PubMed ID: 9890944
[TBL] [Abstract][Full Text] [Related]
11. Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.
Wang WK; Dudek T; Essex M; Lee TH
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4558-62. PubMed ID: 10200301
[TBL] [Abstract][Full Text] [Related]
12. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.
Tsamis F; Gavrilov S; Kajumo F; Seibert C; Kuhmann S; Ketas T; Trkola A; Palani A; Clader JW; Tagat JR; McCombie S; Baroudy B; Moore JP; Sakmar TP; Dragic T
J Virol; 2003 May; 77(9):5201-8. PubMed ID: 12692222
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
15. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
Cormier EG; Tran DN; Yukhayeva L; Olson WC; Dragic T
J Virol; 2001 Jun; 75(12):5541-9. PubMed ID: 11356961
[TBL] [Abstract][Full Text] [Related]
16. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
Foda M; Harada S; Maeda Y
Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.
Hung CS; Vander Heyden N; Ratner L
J Virol; 1999 Oct; 73(10):8216-26. PubMed ID: 10482572
[TBL] [Abstract][Full Text] [Related]
18. CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains.
Genoud S; Kajumo F; Guo Y; Thompson D; Dragic T
J Virol; 1999 Feb; 73(2):1645-8. PubMed ID: 9882373
[TBL] [Abstract][Full Text] [Related]
19. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
20. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5.
Farzan M; Choe H; Vaca L; Martin K; Sun Y; Desjardins E; Ruffing N; Wu L; Wyatt R; Gerard N; Gerard C; Sodroski J
J Virol; 1998 Feb; 72(2):1160-4. PubMed ID: 9445013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
